NovoCure (NVCR) Q2 2025 Earnings

24AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.61
-0.5
-0.39
-0.28

Details

Expected EPS
-0.464086
Actual EPS
-0.31
Surprise EPS
0.15
Surprise Percent
+33.2%

Description

NovoCure (NVCR) has reported earnings of -0.31 per share for Q2 2025.

0 Comments

Share your thoughts